Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia. - Liu, Ge; Liang, Taotao; Ai, Hao; Wang, Shan; Yin, Songke; Wang, Xiaojiao; Wu, Hongfei; Wang, Qian; Zhao, Hongmian; Liu, Xiaojuan; Luv, Xiaodong; Liu, Jia; et al. (Communications Biology, 2026)